Influenza mimetic protein-polymer nanoparticles as antigen delivery vehicles to dendritic cells for cancer immunotherapy
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q1Scopus Q1
- 저널
- NANOSCALE11(29) · pp.13878 · 2019
- 피인용
- Web of Science 9Scopus 10
- FWCI (Scopus)
- 0.5
- JCR IF
- JCR 2018 6.97
- ISSN
- 2040-3364
저자
- 이채연제1저자Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr
- 리자Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr
- Shim, KyuHwanDepartment of Bionano Technology, Gachon University Sungnam Republic of Korea 13120
- An, Seong Soo A.Department of Bionano Technology, Gachon University Sungnam Republic of Korea 13120
- Jang, SunahResearch Center for Bio-Based Chemistry, Korea Research Institute of Chemical Technology (KRICT) Daejeon Korea 34114
- Song, Jae KwangResearch Center for Bio-Based Chemistry, Korea Research Institute of Chemical Technology (KRICT) Daejeon Korea 34114
- Jin, Jun-O교신저자Shanghai Public Health Clinical Center, Shanghai Medical College, Fudan University Shanghai 201508 Email: hpaik@pusan.ac.kr
- 백현종Department of Polymer Science and Engineering, Pusan National University Busan Republic of Korea 46241 Email: hpaik@pusan.ac.kr
초록
© The Royal Society of Chemistry 2019.Stimulation of dendritic cells (DCs) by antigens (Ags) promotes an Ag-specific immune response that kills Ag-expressing pathogens. These biologically inspired nanocarriers have received much attention as tools to deliver cancer Ags to DCs. A polymer-templated protein nanoball having hemagglutinin (H1-NB) that mimics the influenza virus can be used as a cancer Ag delivery vehicle, as DCs show effective phagocytic activities against H1-NB without any adjuvant. In the present study, H1-NB containing ovalbumin (OVA), a model Ag (H1-OVA-NB), was prepared as an anti-cancer agent and evaluated for its effect on anticancer immunity. H1-OVA-NB treatments in C57BL/6 mice enhanced OVA-specific immune activation and efficiently inhibited B16-OVA tumor growth compared to control groups. Our results indicate that H1-NB is an effective carrier for Ag delivery to DCs and promotes immunotherapy to fight cancer.
식별자
- Scopus EID
- 2-s2.0-85069678410
- WoS UID
- 000477704400018



로그인
연구물 목록으로